Filter posts

Session Recap: Digital Health—Early Successes for Investors and Biotech R&D Productivity

Digital health has the potential to improve the life science industry by combining traditional and …

Producing "21st Century Cures" - 2015 U.S. Legislative Outlook with Chairman Upton and Rep. DeGette

BIO President & CEO Jim Greenwood today sat down with Energy & Commerce Committee Chairman …

BIO CEO & Investor Conference Kicks Off in NYC

The 17th Annual BIO CEO & Investor Conference opened today with a record number of partnering …

Getting Ahead of Ebola and Other Infectious Threats—Overturning Assumptions

Ebola was one of the biggest stories of 2014 (with Ebola fighters named the TIME …

How Industry Rates Interactions with the FDA

Kicking off day one of the BIO CEO & Investor Conference in New York City, …

Patients Remain the Focus for the Future of Personalizing Oncology

The 17th Annual BIO CEO & Investor Conference, being held at the Waldorf Astoria in New …

Dow Jones VentureWire: BIO Report on Venture Funding for Therapeutic Innovation

Today, Brian Gormley’s story – Biotech VCs Shift Away From Chronic Diseases, Report Says – …

Announcing the BIO/Bloomberg Intelligence: 2015 Biotech Industry Outlook Survey

Click here for the BIO/Bloomberg Intelligence: 2015 Biotech Industry Outlook Survey. Your investment plans and …

Chairman Upton and Rep. DeGette Op-Ed: Can We Find Cures for 7,000 Diseases?

In a CNN.com op-ed, Energy & Commerce Committee Chairman Fred Upton (R-MI) and Representative Diana …

Voting Now Open for the Buzz of BIO at the 2015 BIO CEO & Investor Conference

The Buzz of BIO contest at the 2015 BIO CEO & Investor Conference recognizes highly innovative …